Cubist Systematic Strategies’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-21,064
| Closed | -$568K | – | 4753 |
|
|
2022
Q4 | $568K | Sell |
21,064
-64,281
| -75% | -$1.69M | ﹤0.01% | 2930 |
|
|
2022
Q3 | $1.53M | Buy |
85,345
+44,709
| +110% | +$714K | 0.01% | 2254 |
|
|
2022
Q2 | $505K | Buy |
40,636
+5,676
| +16% | +$62.6K | ﹤0.01% | 3055 |
|
|
2022
Q1 | $466K | Buy |
34,960
+13,835
| +65% | +$186K | ﹤0.01% | 2579 |
|
|
2021
Q4 | $329K | Sell |
21,125
-24,428
| -54% | -$466K | ﹤0.01% | 2740 |
|
|
2021
Q3 | $1.02M | Buy |
45,553
+33,204
| +269% | +$729K | 0.01% | 1512 |
|
|
2021
Q2 | $281K | Sell |
12,349
-1,275
| -9% | -$26.8K | ﹤0.01% | 2376 |
|
|
2021
Q1 | $280K | Sell |
13,624
-19,897
| -59% | -$453K | ﹤0.01% | 2299 |
|
|
2020
Q4 | $926K | Buy |
33,521
+22,185
| +196% | +$432K | 0.01% | 1430 |
|
|
2020
Q3 | $159K | Sell |
11,336
-9,321
| -45% | -$173K | ﹤0.01% | 2194 |
|
|
2020
Q2 | $426K | Sell |
20,657
-38,106
| -65% | -$518K | 0.01% | 1675 |
|
|
2020
Q1 | $444K | Buy |
58,763
+9,923
| +20% | +$111K | 0.01% | 1317 |
|
|
2019
Q4 | $758K | Buy |
48,840
+8,694
| +22% | +$87.6K | 0.01% | 1324 |
|
|
2019
Q3 | $209K | Buy |
40,146
+3,667
| +10% | +$27.2K | ﹤0.01% | 1750 |
|
|
2019
Q2 | $330K | Buy |
+36,479
| New | +$544K | 0.01% | 1735 |
|
|
2017
Q4 | – | Sell |
-183
| Closed | -$3K | – | 2152 |
|
|
2017
Q3 | $3K | Buy |
+183
| New | +$2.23K | ﹤0.01% | 1807 |
|
|
2017
Q1 | – | Sell |
-3,081
| Closed | -$38K | – | 1925 |
|
|
2016
Q4 | $38K | Buy |
+3,081
| New | +$35.7K | ﹤0.01% | 1605 |
|
Other funds holding MYOV
Cubist Systematic Strategies's MYOV Position: Q1 2023 in Review
Cubist Systematic Strategies sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 21,064 shares — an estimated $568K sold.
Cubist Systematic Strategies first reported a position in MYOV in Q4 2016 and held it in 17 quarters. The position peaked at $1.53M in Q3 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Cubist Systematic Strategies reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 21,064 Myovant Sciences Ltd. shares in Q1 2023, an estimated $568K.
- Cubist Systematic Strategies first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 17 quarters.
- Cubist Systematic Strategies's Myovant Sciences Ltd. position peaked at $1.53M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.